Mucinex knocked Vicks off the top spot for monthly TV ad impressions as pharma brands generated significant coverage from ...
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
(Reuters) - Regeneron (NASDAQ: REGN) Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing ...
Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolled SAN FRANCISCO and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., ...
Sanofi SA (SNY) reports robust sales growth driven by Dupixent and vaccines, while planning a significant share buyback to ...
Looking ahead, Sanofi has announced an ambitious share buyback program worth 5 billion euros for 2025, signaling strong confidence in its future prospects. The company projects mid to high ...
Dupixent continues leading among Sanofi’s portfolio, and it’s poised for up to $20 billion in peak sales. Read my SNY ...
new shops and products, travel destinations, art and cultural events, celebrity style, and high-end real estate as well as access to print features and images from the AD archives.
Netflix has introduced a new type of extra member account: extra members with ads. The streamer announced the new offering in a shareholder letter on Tuesday before its fourth-quarter earnings call.
Rinvoq's total estimated spending came in about $40 million behind Skyrizi's total last year, according to iSpot.TV, while Dupixent's total ... $223 million behind six ads—half in major ...
An advocacy group founded by former Vice President Mike Pence launched a six-figure ad campaign Wednesday opposing President Trump’s nomination of Robert F. Kennedy Jr. to lead the Department of ...
So every company wants a piece of the pie. To stand out, companies put a ton of time, effort and cash into creating memorable ads. In the age of social media, making an impact is even more crucial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results